NANJING, China, Sept. 14, 2024 /PRNewswire/ -- On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and Dexborneol sublingual tablets), an innovative drug for stroke, has been granted the Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for the treatment of Acute Ischemic Stroke (AIS). Sanbexin sublingual tablets is the first innovative drug in the world to be designated with the Breakthrough Therapy by the FDA for the treatment of stroke.
The Breakthrough Therapy designation stems from the provisions of 《Food and Drug Administration Safety and Innovation Act》. It is designed to expedite the development and regulatory review of drugs for treating serious diseases and addressing significant unmet medical needs. The designation will be beneficial for the drugs to obtain the FDA's guidance in the clinical development, accelerate the overseas clinical development process, and is also expected to significantly shorten the time for marketing review through the priority review designation.
The Breakthrough Therapy designation is based on the significant improvement in efficacy metrics demonstrated by the sublingual tablets in a previous clinical study. The data from a multicenter, randomized, double-blind, parallel, placebo-controlled Phase III clinical study in China for the treatment of AIS demonstrated that Sanbexin sublingual tablets significantly improved neurological recovery and independent living ability in patients with AIS compared to placebo, meeting the expected efficacy endpoints with a favorable safety profile. JAMA Neurology published the study's key findings online.
The designation will be beneficial for Simcere to obtain the FDA's guidance in the clinical development of Sanbexin sublingual tablets, accelerate the overseas clinical development process, and is also expected to significantly shorten the time for marketing review through the priority review designation.
According to a recent article in The Lancet, stroke is the second leading cause of death and disability worldwide, with 12 million new cases and 6.6 million deaths each year. Among them, acute ischemic stroke is the most common type of stroke, accounting for about 70% of all strokes, and constituting a heavy disease burden for all countries around the world. The efficacy of acute ischemic stroke treatment is highly time-dependent. Receiving treatment as early as possible will help patients to improve their disease outcome and avoid disability.
Sanbexin sublingual tablets is a brain cytoprotective agent composed of edaravone and dexborneol, two active ingredients with synergistic anti-oxidant and anti-inflammatory effects, which can significantly reduce brain cell injury or impairment caused by AIS. Such unique sublingual formulation can quickly disintegrate once in contact with the saliva once place under the tongue and can be absorbed into the blood through the sublingual venous plexus, which is expected to increase the flexibility of stroke treatment. Sequential therapy consisting of the marketed Sanbexin concentrated solution for Injection. These two formulae enable patients to receive a complete course of treatment in and outside of the hospital.
On June 28, 2023, the new drug application (NDA) for Sanbexin sublingual tablets in China is accepted by the National Medical Products Administration. The first indication is for the improvement of neurological symptoms, daily activities, and functional impairment due to AIS. Phase I clinical trials for Sanbexin sublingual tablets on healthy volunteers have been completed in the United States.
CONTACT: Haoyun Huang, huanghaoyun@simcere.com
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration
Full product lineup addresses cleaning needs across indoor facilities, parking garages and outdoor spaces.
LAS VEGAS, Nov. 20, 2026 /PRNewswire/ -- VIGGO, a leading provider of commercial cleaning robots, showcased its full product lineup at ISSA Show North America 2026 (November 17–19), introducing its new Mix1Pro commercial cleaning robot to the global market.
The launch comes as commercial cleaning robots expand into more public spaces. According to IDC, global shipments reached approximately 58,000 units in 2025, an increase of 83.8% year over year. Building services, retail, transportation, hospitality and food service together accounted for 72.9% of shipments. For facility operators, long-term adoption depends on both cleaning performance and a robot's ability to adapt to changing conditions and work effectively alongside staff. Mix1Pro addresses these requirements through advances in navigation, cleaning and automated servicing.
Adaptive Navigation for Complex Environments
Mix1Pro combines 3D LiDAR with multi-sensor fusion to deliver 360-degree spatial perception. By detecting surrounding structures and tracking changes in its environment, the robot supports stable localization and responsive obstacle avoidance in complex, dynamic spaces.
Versatile Floor Care in One Machine
Mix1Pro sweeps, scrubs, vacuums and mops simultaneously in a single pass. Capable of both hard-floor care and carpet vacuuming, it accommodates diverse surfaces within a single facility. A 20.5-inch cleaning width supports efficient coverage, while an optional UV-C module adds disinfection capability.
Automated Servicing and Simpler Maintenance
Mix1Pro's fully automated docking station handles charging, clean-water refilling, wastewater draining, detergent dosing and self-cleaning of the scrubbing roller and roller brush. These functions reduce routine manual intervention and support extended autonomous operation.
A quick-release design simplifies daily maintenance, while an integrated ergonomic power-assisted handle and a 10-inch touchscreen make manual relocation and on-device operation more convenient.
Designed for shopping centers, supermarkets, hospitals, schools, hotels and office buildings, Mix1Pro accommodates varied floor types and cleaning requirements. Its quiet, efficient operation helps facilities maintain cleanliness alongside daily business activities and public services.
A Broader Portfolio for Specialized Cleaning Needs
Also on display were VIGGO's established product lines for other commercial environments.
The newly upgraded SC50ProPlus features hardware and software enhancements tailored to parking garages. Building on the SC50 series' versatility across indoor environments, these upgrades further strengthen its ability to sustain cleaning operations in these demanding settings.
The SC80 series draws on extensive deployment experience in industrial and logistics facilities across multiple international markets. Its long runtime and deep-cleaning capabilities address the demands of large areas and intensive cleaning schedules.
Designed for outdoor areas within enclosed or controlled-access sites, the S100-N is already operating across the Middle East, Europe and Asia. It provides autonomous sweeping for plazas, parks and roads within managed properties.
Practical Value for Facility Operators
VIGGO's commercial cleaning robot portfolio spans indoor and outdoor applications, with deployments in approximately 40 countries and regions. Sustained use across industrial facilities, transportation hubs and commercial properties has provided experience with a wide range of operating conditions.
From routine floor care to demanding cleaning tasks, the portfolio helps operators reduce manual workloads, simplify upkeep and maintain more consistent cleaning performance. By assigning repetitive cleaning work to robots, facilities can direct staff toward higher-value services and tasks requiring human judgment—improving both the quality of their spaces and the efficiency of their operations.
Media Contact:
DuWenjun
duwenjun@velobotics.ai
+8618513148596
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
VIGGO Launches Mix1Pro Commercial Cleaning Robot at ISSA Show North America 2026